Breakdown of excess cost of care due to sepsis.

(DOCX)</p

Characteristics of cancer patients with sepsis by malignancy type.

Characteristics of cancer patients with sepsis by malignancy type.</p

Cumulative cost of care ($CAD 2018, 95% CI) between sepsis cases and matched controls.

Cumulative cost of care ($CAD 2018, 95% CI) between sepsis cases and matched controls.</p

Kaplan-Meier survival curves comparing sepsis cases to no sepsis controls.

(DOCX)</p

Sub-group analyses results.

(DOCX)</p

Variations in the 1-year cumulative excess cost by sex and age groups.

(A) Haematolgy. (B) Solid tumour. The dotted vertical line represents the excess cost presented in our main analysis (overall grouped average). Error bars represent the 95% confidence intervals.</p

Descriptive statistics of sepsis cases vs. matched controls by malignancy types.

(DOCX)</p

Descriptive statistics of sepsis cases vs. unmatched cases by malignancy types.

(DOCX)</p

Mean monthly cost of care by malignancy type.

(A) Haematolgy. (B) Solid tumour. The shaded area represents excess cost associated with sepsis, solid line represents mean monthly cost of care among sepsis (cases) and dotted line for no sepsis (controls).</p

Data source.

(DOCX)</p